Cost-Effectiveness Analysis of Supervised Exercise Training in Men with Prostate Cancer Previously Treated with Radiation Therapy and Androgen-Deprivation Therapy.
Kim EdmundsPenny ReevesPaul A ScuffhamDaniel A GalvãoRobert U NewtonMark A JonesNigel A SpryDennis R TaaffeDavid JosephSuzanne K ChambersHaitham W TuffahaPublished in: Applied health economics and health policy (2021)
This is the first cost-effectiveness analysis of exercise for PCa survivors. The intervention was effective, but unlikely to be cost-effective at the generally accepted willingness-to-pay of AU$50,000 per QALY. It is likely that evidence to support cost savings from post-intervention outcomes would reveal greater benefits and contribute to a more comprehensive cost-effectiveness analysis. Future RCTs should incorporate longer follow-up durations and collection of data to support modelling to capture future health benefits. Measures of quality of life or utility more sensitive to the impact of physical activity would also improve future economic evaluations.
Keyphrases
- prostate cancer
- physical activity
- current status
- radiation therapy
- randomized controlled trial
- healthcare
- public health
- radical prostatectomy
- high intensity
- young adults
- mental health
- skeletal muscle
- body mass index
- type diabetes
- stem cells
- sensitive detection
- electronic health record
- reduced graphene oxide
- social media
- newly diagnosed
- middle aged
- insulin resistance
- quantum dots
- health promotion
- cell therapy
- data analysis
- human health